SCHEMBL2994557

SCHEMBL2994557

CCOC(=O)N1CCc2sc(C(F)(F)F)c(Cl)c2CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 1/20 0.43
KDM4E B2RXH2 5/20 0.42
MAPT P10636 4/20 0.42
GAA P10253 2/20 0.42
ALDH1A1 P00352 8/20 0.41
HPGD P15428 4/20 0.41
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
POLB P06746 2/20 0.41
RXFP1 Q9HBX9 3/20 0.40
ADORA1 P30542 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 1/20 0.38
ALOX15 P16050 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2997907 0.89 MAPT (0.43) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL3004283 0.85 ACACA (0.43) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL3004061 0.83 MAPT (0.46) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL2992491 0.81 MAPT (0.44) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL3002194 0.78 MAPT (0.44) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL2994362 0.74 MAPT (0.44) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL1180562 0.73 MAPT (0.43) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL1878380 0.73 MAPT (0.41) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL1180375 0.72 MAPT (0.46) ACACAKDM4EMAPTGAAALDH1A1
SCHEMBL1181645 0.72 MAPT (0.46) ACACAKDM4EMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778243-B1 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS INC (US) 2012-10-31 EP disclosed
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators BENNANI YOUSSEF L 2010-07-29 US disclosed
US-7718647-B2 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. (US) 2010-05-18 US disclosed
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators HTR5A, HTR4, HTR7 ACACA 2718/4885KDM4E 964/4885MAPT 4268/4885
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators HTR5A, HTR4, HTR2C ACACA 3059/4885KDM4E 692/4885MAPT 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.